NCT01939067

Brief Summary

This study is designed to evaluate the effect of heated humidified high flow nasal cannula (HHHFNC) as compared to noninvasive nasal continuous positive airway pressure (NCPAP) on lung function as a measure of lung injury in preterm infants born at 28 to 37 weeks gestation requiring continuing respiratory support.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2014

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2013

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 11, 2013

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

September 15, 2015

Status Verified

September 1, 2015

Enrollment Period

Same day

First QC Date

August 30, 2013

Last Update Submit

September 14, 2015

Conditions

Keywords

respiratory distressHeated Humidified High Flow Nasal Cannula (HHHFNC)HHHFNCnoninvasive nasal continuous positive airway pressure (NCPAP)NCPAP

Outcome Measures

Primary Outcomes (1)

  • Pulmonary mechanics and chest wall asynchrony measures.

    Pulmonary mechanics measures consisting of dynamic lung compliance, airway resistance, and work of breathing and chest wall asynchrony measures consisting of thoracoabdominal asynchrony, labored breathing index and rib cage to abdominal phase relation during the total breath are measured in preterm infants treated with HHHFNC and compared to the same measurements in preterm infants treated with NCPAP.

    2 years

Secondary Outcomes (3)

  • Duration of respiratory support or oxygen use up to the time of discharge from the NICU.

    2 years

  • The incidence of potential adverse outcomes associated with HHHFNC or NCPAP.

    2 years

  • Time needed to establish full enteral feeds

    2 years

Study Arms (2)

HHHFNC

OTHER

Treatment of respiratory distress by Heated Humidified High Flow Nasal Cannula (HHHFNC). Escalation of the ventilatory support per protocol and the attending physician.

Device: Heated Humidified High Flow Nasal Cannula

NCPAP

OTHER

Treatment of respiratory distress by nasal continuous positive airway pressure (NCPAP). Escalation of the ventilatory support per protocol and the attending physician.

Device: Nasal Continuous Positive Airway Pressure

Interventions

Biweekly measurement of lung mechanics (dynamic compliance, airway resistance, work of breathing) and chest wall asynchrony measures while on HHHFNC and weekly when weaned off until 40 weeks post conceptional age or discharge. Recording of the level and the type of respiratory support and all cross over respiratory support devices. Recording of all growth parameters, neonatal morbidities and therapies.

HHHFNC

Biweekly measurement of lung mechanics (dynamic compliance, airway resistance, work of breathing) and chest wall asynchrony measures while on NCPAP and weekly when weaned off until 40 weeks post conceptional age or discharge. Recording of the level and the type of respiratory support and all cross over respiratory support devices. Recording of all growth parameters, neonatal morbidities and therapies.

NCPAP

Eligibility Criteria

Age2 Hours - 72 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Birth weight greater than or equal to 1000 grams.
  • Gestational age at birth between 28 weeks and 37 weeks (28 0/7 to 37 6/7 weeks inclusive).
  • Candidate for non-invasive respiratory support as a result of:
  • An intention to manage the infant with non-invasive (no endotracheal tube) respiratory support.
  • An intention to extubate an infant being managed with intubated respiratory support to non-invasive respiratory support.
  • Subjects must have a guardian or acceptable surrogate capable of giving consent on his/her behalf.

You may not qualify if:

  • Birth weight less than 1000 grams.
  • Estimated gestation at birth less than 28 weeks or greater than 37 6/7 weeks.
  • Active air leak syndrome.
  • Subjects will not be eligible if they are not considered viable.
  • Infants with abnormalities of the upper and lower airways
  • Infants with significant abdominal or respiratory malformations .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennsylvania Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

DyspneaLung Injury

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung DiseasesThoracic InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Soraya Abbasi, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2013

First Posted

September 11, 2013

Study Start

March 1, 2014

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

September 15, 2015

Record last verified: 2015-09

Locations